ETNB

89bio Stock Price

29.98
0.29 (0.98%)
Upgrade to Real-Time
Regular Market
29.98
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
89bio Inc ETNB NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.29 0.98% 29.98 29.66 30.93 29.81 29.69 13:07:07
Bid Price Ask Price Spread Spread % News
29.87 30.00 0.13 0.43% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
415 25,384 $ 30.08 $ 763,511 150,555 14.0001 - 47.2532
Last Trade Time Type Quantity Stock Price Currency
13:21:29 8 $ 29.98 USD

89bio Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 505.23M 16.85M 7.06M $ - $ - -27.12 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 109.09k -

more financials information »

89bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ETNB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week32.1633.3628.2430.6956,636-2.18-6.78%
1 Month31.8336.1828.2431.7660,177-1.85-5.81%
3 Months27.9937.089918.013828.70101,3161.997.11%
6 Months29.5447.253214.000127.8273,0610.441.49%
1 Year20.0047.253214.000127.6776,8599.9849.9%
3 Years20.0047.253214.000127.6776,8599.9849.9%
5 Years20.0047.253214.000127.6776,8599.9849.9%

89bio Description

89bio Inc a United States-based clinical-stage biopharmaceutical company focused on the development of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, BIO89-100, is a long-acting glycopegylated fibroblast growth factor 21 (FGF21) analogue.


Your Recent History
NASDAQ
ETNB
89bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.